Summary.
Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC50 of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.
Article PDF
Similar content being viewed by others
References
K Anand J Ziebuhr P Wadhwani JR Mesters R Hilgenfeld (2003) ArticleTitleCoronavirus main proteinase (3CL(pro)) structure: Basis for design of anti-SARS drugs Science 300 1763–1767 Occurrence Handle12746549 Occurrence Handle10.1126/science.1085658 Occurrence Handle1:CAS:528:DC%2BD3sXksVKisLk%3D
RD Bron YC Martin (1996) ArticleTitleUse of structure-activity data to compare structure-based clustering: methods and descriptors for use in compound selection J Chem Info Comput Sci 36 572–584 Occurrence Handle10.1021/ci9501047
KC Chou (2004a) ArticleTitleReview: Structural bioinformatics and its impact to biomedical science Curr Med Chem 11 2105–2134 Occurrence Handle1:CAS:528:DC%2BD2cXlslWltbw%3D
KC Chou (2004b) ArticleTitleModelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5 Biochem Biophys Res Commun 316 636–642 Occurrence Handle10.1016/j.bbrc.2004.02.098 Occurrence Handle1:CAS:528:DC%2BD2cXitFKgs7w%3D
KC Chou (2004c) ArticleTitleInsights from modelling three-dimensional structures of the human potassium and sodium channels J Proteome Res 3 856–861 Occurrence Handle10.1021/pr049931q Occurrence Handle1:CAS:528:DC%2BD2cXktVKmtL8%3D
KC Chou (2004d) ArticleTitleInsights from modelling the tertiary structure of BACE2 J Proteome Res 3 1069–1072 Occurrence Handle10.1021/pr049905s Occurrence Handle1:CAS:528:DC%2BD2cXmsVSlu7k%3D
KC Chou (2004e) ArticleTitleInsights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor Biochem Biophys Res Commun 319 433–438 Occurrence Handle10.1016/j.bbrc.2004.05.016 Occurrence Handle1:CAS:528:DC%2BD2cXkslSjtLg%3D
KC Chou (2005a) ArticleTitleCoupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein J Proteome Res 4 1681–1686 Occurrence Handle10.1021/pr050145a Occurrence Handle1:CAS:528:DC%2BD2MXmsVyitro%3D
KC Chou (2005b) ArticleTitleModeling the tertiary structure of human cathepsin-E Biochem Biophys Res Commun 331 56–60 Occurrence Handle10.1016/j.bbrc.2005.03.123 Occurrence Handle1:CAS:528:DC%2BD2MXjsFChs7k%3D
KC Chou WJ Howe (2002) ArticleTitlePrediction of the tertiary structure of the beta-secretase zymogen Biochem Biophys Res Commun 292 702–708 Occurrence Handle11922623 Occurrence Handle10.1006/bbrc.2002.6686 Occurrence Handle1:CAS:528:DC%2BD38XitlGnu70%3D
KC Chou KD Watenpaugh RL Heinrikson (1999) ArticleTitleA Model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator Biochem Biophys Res Commun 259 420–428 Occurrence Handle10362524 Occurrence Handle10.1006/bbrc.1999.0792 Occurrence Handle1:CAS:528:DyaK1MXjs1Smu7o%3D
KC Chou AG Tomasselli RL Heinrikson (2000) ArticleTitlePrediction of the tertiary structure of a caspase-9/inhibitor complex FEBS Lett 470 249–256 Occurrence Handle10745077 Occurrence Handle10.1016/S0014-5793(00)01333-8 Occurrence Handle1:CAS:528:DC%2BD3cXitVSrurw%3D
KC Chou DQ Wei WZ Zhong (2003) ArticleTitleBinding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun 308 148–151 Occurrence Handle12890493 Occurrence Handle10.1016/S0006-291X(03)01342-1 Occurrence Handle1:CAS:528:DC%2BD3sXlvVCktbk%3D
QS Du SQ Wang ZQ Jiang WN Gao Y Li DQ Wei KC Chou (2005) ArticleTitleApplication of Bioinformatics in search for cleavable peptides of SARS CoV Mpro and chemical modification of octapeptides Med Chem 1 209–213 Occurrence Handle16787316 Occurrence Handle10.2174/1573406053765468 Occurrence Handle1:CAS:528:DC%2BD2MXksVahurc%3D
TJ Ewing S Makino AG Skillman ID Kuntz (2001) ArticleTitleDock 4.0: search strategies for automated molecular docking of flexible molecule databases J Comput Aided Mol Des 15 411–428 Occurrence Handle11394736 Occurrence Handle10.1023/A:1011115820450 Occurrence Handle1:CAS:528:DC%2BD3MXktVSlsbc%3D
S Graham NG Dhaval JR Andrew DR Jacqueline LD Scott B Paul (2005) ArticleTitleInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Proc Natl Acad Sci OSA 102 11876–11881 Occurrence Handle10.1073/pnas.0505577102 Occurrence Handle1:CAS:528:DC%2BD2MXpsFGgurw%3D
Y Guan BJ Zheng YQ He XL Liu ZX Zhuang CL Cheung SW Luo PH Li LJ Zhang YJ Guan et al. (2003) ArticleTitleIsolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 276–278 Occurrence Handle12958366 Occurrence Handle10.1126/science.1087139 Occurrence Handle1:CAS:528:DC%2BD3sXnvFWgtL0%3D
G Guncar G Pungercic I Klemencic V Turk D Turk (1999) ArticleTitleCrystal structure of Mhc class II associated P41 II fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S EMBO J 18 793–803 Occurrence Handle10022822 Occurrence Handle10.1093/emboj/18.4.793 Occurrence Handle1:CAS:528:DyaK1MXhs1WrsrY%3D
H Jeffrey Q Diana ZY Zhong C Barbara (1995) ArticleTitleInhibition of /I-amyloid formation identifies proteolytic precursors and SubceUular site of catabolism Neuron 14 651–659 Occurrence Handle10.1016/0896-6273(95)90322-4
H Kakegawa (1993) ArticleTitleParticapation of cathepsin L in bone resorption FEBS Lett 321 247–250 Occurrence Handle8477857 Occurrence Handle10.1016/0014-5793(93)80118-E Occurrence Handle1:CAS:528:DyaK3sXktVGrsLY%3D
Kuntz ID, Demetri TM, Lang PT (2005) DOCK 5.3 User Manual. University of California
CA Lipinski F Lombardo BW Dominy PJ Feeney (1997) ArticleTitleExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 23 2–25 Occurrence Handle10.1016/S0169-409X(96)00423-1
E Mary ME McGrath (1999) ArticleTitleThe lysosomal cysteine proteases Annu Rev Biophys Biomol Struct 28 181–204 Occurrence Handle10.1146/annurev.biophys.28.1.181
PA Rota MS Oberste SS Monroe WA Nix R Campagnoli JP Icenogle S Penaranda B Bankamp K Maher MH Chen et al. (2003) ArticleTitleCharacterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 1394–1399 Occurrence Handle12730500 Occurrence Handle10.1126/science.1085952 Occurrence Handle1:CAS:528:DC%2BD3sXktFGkt7Y%3D
XG Sheng J Wu H Liu JI Zhang (2004) ArticleTitleStudies on the components of the fatty acid of Artemisia annua Grassland Turf 4 68–70
RP Sheridan MD Miller DJ Underwood SK Kearsley (1996) ArticleTitleChemical similarity using geometric atom pair descriptors J Chem Info Comput Sci 36 128–136 Occurrence Handle10.1021/ci950275b Occurrence Handle1:CAS:528:DyaK28XhsFKitA%3D%3D
M Shujaath RA Michael SW Jeffery B Philippe (1998) Biochem Biophys Res Commun 157 1117–1123
DQ Wei QS Du H Sun KC Chou (2006) ArticleTitleInsights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands Biochem Biophys Res Commun 344 1048–1055 Occurrence Handle16647045 Occurrence Handle10.1016/j.bbrc.2006.03.210 Occurrence Handle1:CAS:528:DC%2BD28XktVOqsL4%3D
H Yang M Yang Y Ding Y Liu Z Lou Z Zhou L Sun L Mo S Ye H Pang GF Gao K Anand M Bartlam R Hilgenfeld ZH Rao (2003) ArticleTitleThe crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Proc Natl Acad Sci USA 100 13190–13195 Occurrence Handle14585926 Occurrence Handle10.1073/pnas.1835675100 Occurrence Handle1:CAS:528:DC%2BD3sXptFOju7s%3D
GP Zhou FA Troy Suffix2nd (2003) ArticleTitleCharacterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions Glycobiology 13 51–71 Occurrence Handle12626407 Occurrence Handle10.1093/glycob/cwg008 Occurrence Handle1:CAS:528:DC%2BD3sXjt12qtrg%3D
GP Zhou FA Troy Suffix2nd (2005a) ArticleTitleNMR study of the preferred membrane orientation of polyisoprenols (dolichol) and the impact of their complex with polyisoprenyl recognition sequence peptides on membrane structure Glycobiology 15 347–359 Occurrence Handle10.1093/glycob/cwi016
GP Zhou FA Troy (2005b) ArticleTitleNMR studies on how the binding complex of polyisoprenol recognition sequence peptides and polyisoprenols can modulate membrane structure Curr Protein Peptide Sci 6 399–411 Occurrence Handle10.2174/138920305774329377
JJ Zhou GR Xie XJ Yan (2004) Traditional chinese medicines: molecular structures, natural sources and applications Chemical Industry Press China
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, SQ., Du, QS., Zhao, K. et al. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids 33, 129–135 (2007). https://doi.org/10.1007/s00726-006-0403-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-006-0403-1